Cave James L. 4
4 · Teladoc Health, Inc. · Filed Sep 4, 2024
Insider Transaction Report
Form 4
Cave James L.
INTERIM CAO
Transactions
- Sale
Common Stock
2024-09-03$7.16/sh−555$3,976→ 13,808 total - Exercise/Conversion
Restricted Stock Units
2024-08-30−1,162→ 6,977 total→ Common Stock (1,162 underlying) - Exercise/Conversion
Common Stock
2024-08-30+339→ 12,818 total - Exercise/Conversion
Common Stock
2024-08-30+383→ 13,201 total - Exercise/Conversion
Common Stock
2024-08-30+1,162→ 14,363 total - Exercise/Conversion
Restricted Stock Units
2024-08-30−339→ 678 total→ Common Stock (339 underlying) - Exercise/Conversion
Restricted Stock Units
2024-08-30−383→ 1,151 total→ Common Stock (383 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
- [F2]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
- [F3]On April 1, 2022, the reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F4]On June 1, 2022, the reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F5]On March 3, 2023, the reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.